Development of inhibitors in hemophilia A: An illustrated review
Abstract This illustrated review focuses on the development of inhibitors in patients with congenital hemophilia, which is the most serious treatment‐related complication in these patients. Hemophilia A (HA) is an inherited X‐linked bleeding disorder affecting 1:5000‐10 000 newborn males worldwide....
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-07-01
|
| Series: | Research and Practice in Thrombosis and Haemostasis |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/rth2.12335 |